O uso de melatonina como terapia adjuvante da periodontite: uma revisão sistemática com meta análise e relatos de casos clínicos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Periodontitis, a disease that affects the supporting tissues of the teeth, is
associated with oxidative stress and metabolic conditions such as obesity. This
metabolic disorder impacts the immune response, promotes inflammatory
imbalances, and exacerbates periodontal tissue destruction. Additionally, low
melatonin levels have been correlated with obesity and periodontitis, creating a
systemic pro-inflammatory environment. Melatonin, a hormone secreted by the
pineal gland and oral tissues, possesses antioxidant, immunomodulatory, and
anti-inflammatory properties that may potentially improve the outcomes of nonsurgical periodontal therapy (NSPT). This study aimed to evaluate the
effectiveness of melatonin as an adjuvant to NSPT in individuals with obesity and
periodontal disease. A systematic review with meta-analysis was conducted,
registered in PROSPERO (CRD42023472889), including 15 studies investigating
clinical and biochemical parameters. A total of 845 periodontal sites were
assessed (424 treated with NSPT combined with melatonin and 421 treated with
NSPT alone or placebo). The search covered five major databases and gray
literature. The risk of bias was analyzed using the RoB 2.0 tool, and the quality
of evidence was assessed using the GRADE framework. The results showed
significant improvements in clinical parameters such as probing depth (PD),
clinical attachment level (CAL), gingival index (GI), and plaque index (PI), as well
as reductions in pro-inflammatory biomarkers (IL-1β, IL-6, TNF-α), RANKL, and
HbA1c in the melatonin + NSPT group. Although the certainty of evidence was
classified as low to moderate, most studies demonstrated a low risk of bias. Case
reports complemented these findings, utilizing an experimental 1% melatonin gel
in a split-mouth model. After three months of follow-up, improvements in clinical parameters were observed compared to the control group treated with a placebo
gel. Melatonin has shown potential as an adjuvant to NSPT, promoting clinical
benefits and reducing systemic inflammation. However, further studies are
needed to establish administration protocols, optimal dosages, and long-term
effects, particularly in patients with obesity and periodontitis.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

